Newly Diagnosed Type 2 Diabetes With Renal Impairment
A 64-year-old man is newly diagnosed with type 2 diabetes after a routine screening. He has hypertension and a body mass index of 31 kg/m². Laboratory results: HbA1c 8.6%, fasting glucose 9.4 mmol/L, eGFR 42 mL/min/1.73 m², urine albumin-to-creatinine ratio 85 mg/mmol (moderately-to-severely increased), potassium 4.9 mmol/L. He takes amlodipine 10 mg daily and atorvastatin 20 mg daily. He has no history of cardiovascular disease, no heart failure, and no prior hypoglycemia. He asks whether he needs insulin and whether his kidneys will fail.
1. Propose an initial glucose-lowering regimen, justifying the choice of agent given his renal function and comorbidity profile.
Read the worked answer
Preferred initial approach:
- Metformin can be started at a reduced dose given eGFR 42 (continue with dose reduction; avoid initiation if eGFR <30; reassess if it falls further). It is first-line, weight-neutral, and inexpensive.
- Add an SGLT2 inhibitor (e.g., empagliflozin or dapagliflozin), which is indicated for diabetic kidney disease with albuminuria and reduces progression of CKD and cardiovascular events independent of glucose lowering. Check eGFR thresholds for initiation (typically ≥20–25 depending on agent) and counsel on genital mycotic infections, volume depletion, and sick-day rules.
- Alternatively or additionally, a GLP-1 receptor agonist with proven cardiovascular/renal benefit can be considered, especially for weight loss.
- Insulin is not mandatory at HbA1c 8.6% without catabolic features; it may be used if symptoms of hyperglycemia are severe or if targets are not met.
- Avoid sulfonylureas as first choice here because of hypoglycemia risk in CKD; avoid certain DPP-4 inhibitors requiring renal dose adjustment without outcome benefit. Set an individualized HbA1c target (e.g., ~7%).
2. How would you manage his blood pressure and albuminuria, and what monitoring is required?
Read the worked answer
Blood pressure and kidney protection:
- Target BP generally <130/80 mmHg in diabetes with CKD.
- Add an ACE inhibitor or ARB (e.g., ramipril or losartan) for albuminuria, titrated to the maximum tolerated dose, with potassium and creatinine checked 1–2 weeks after initiation and after each dose increase. A small creatinine rise (<30%) is acceptable.
- Do not combine ACE inhibitor and ARB.
- Continue statin for cardiovascular risk; consider intensity based on overall risk.
- Monitor: eGFR, potassium, urine albumin-to-creatinine ratio, and BP at each visit; reinforce smoking cessation, sodium restriction, and weight management.
- Sick-day guidance: hold metformin, SGLT2 inhibitor, and ACE inhibitor/ARB during acute illness with dehydration.
3. The patient asks, "Will I end up on dialysis?" Give a medically accurate, supportive response.
Read the worked answer
Respond honestly but reassuringly:
- Progression is not inevitable. With good blood pressure control, albuminuria reduction (ACE inhibitor/ARB, SGLT2 inhibitor), glycemic control, and avoidance of nephrotoxins, many patients stabilize or progress slowly.
- His eGFR of 42 with significant albuminuria places him at moderate-to-high risk, so regular monitoring (eGFR and albumin every 3–6 months) is needed.
- Emphasize controllable factors: BP, glucose, smoking, weight, salt intake, avoiding NSAIDs and dehydration.
- Explain that even if kidney function declines, planning is proactive, not a prediction of dialysis; early nephrology referral allows preparation and preservation strategies.
- Avoid overpromising; frame the message as partnership and monitoring rather than a fixed outcome.